Aidoc
Clinical AI platform for radiology and enterprise imaging workflows.
Last updated: June 5, 2026
Back to directoryRadiotherapy auto-contouring software that generates CT and MR segmentation templates for trained clinicians to review, edit, and approve.
Radiation oncology programs that want guideline-based segmentation coverage across major anatomical sites and can commission local clinician-review workflows.
Compare within workflow: Medical imaging and radiology · comparison shortlist · source index
Product-specific review. These product-specific signals summarize what the cited sources imply before treating MVision Contour+ as safe for a local clinical, operational, or research workflow.
| Regulatory / FDA | Treat as high-risk radiotherapy image-analysis software and verify the exact FDA record, version, CT/MR scope, anatomy, intended users, and real-time adaptive planning exclusions. |
|---|---|
| Privacy | Review cloud versus local deployment, DICOM transfer, pseudonymization, TLS encryption, support access, retention, BAA terms, and whether images or contours are reused for model development. |
| Evidence | Commission by cancer site, scanner, CT and MR protocol, contouring guideline, outlier anatomy, edit burden, and plan-quality impact before relying on vendor time-saving claims. |
| Workflow | Best governed as an initial contour-template generator with radiation oncologist review, dosimetrist editing, physicist QA, exception handling, and fallback manual contouring. |
MVision describes Contour+ as AI-powered radiotherapy auto-segmentation for organs-at-risk and lymph-node areas, delivered through Workspace+ and GBS workflows; FDA summaries for Contour+ state that CT and MR contours are initial templates that qualified professionals must visualize, review, modify, and approve before clinical use.
Not for: Lesion or tumor detection, real-time adaptive planning, unreviewed contour acceptance, or use outside the currently cleared modality, anatomy, geography, and labeling.
Use these links to confirm current claims, terms, regulatory status, pricing, and deployment requirements.